Kekoa OÜ

Active Registry code 16422401 OÜ Tallinn Registered 14 Jan 2022
Compare

Kekoa OÜ is a OÜ based in Tallinn, registry code 16422401, status: active. Main activity: Research and experimental development on biotechnology. Its annual report for 2023 shows revenue of €5 818 and 1 employees.

Turnover
—
State taxes
1 691 €
↑ 81.8% vs Q2 2023
Labour taxes
1 833 €
↑ 81.3% vs Q2 2023
Employees
—

Q3 2023 · data from the Tax and Customs Board (EMTA)

Position in the industry Scientific research and development · EMTAK 72

  • Revenue · 2023 5 818 €
    industry median 76 € · companies in the industry: 1 030
  • Net profit margin · 2023 11.4 %
    industry median 16.8 % · companies in the industry: 596

Taxes and turnover

Q2 2023 – Q3 2023
Labour taxes per employee, € Q2 2023: 1 011 € · industry median 1 733 € · above 34% of the industry
05001 0001 5002 0002 500Q2 2023 Company: 1 011 € Industry median: 1 733 €Q2·23Q3 2023 Company: — Industry median: 2 003 €Q3·2305001 0001 5002 0002 500Q2 2023 Company: 1 011 € Industry median: 1 733 €Q3 2023 Company: — Industry median: 2 003 €Q3·23
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Employees Q2 2023: 1
0.00.20.40.60.81.0Q2 2023 Company: 1Q2·23Q3 2023 Company: —Q3·230.00.20.40.60.81.0Q2 2023 Company: 1Q3 2023 Company: —Q3·23
State taxes, € Q3 2023: 1 691 € · +81.8% vs Q2 2023
05001 0001 5002 000Q2 2023 Company: 930 €Q2·23Q3 2023 Company: 1 691 €Q3·2305001 0001 5002 000Q2 2023 Company: 930 €Q3 2023 Company: 1 691 €Q3·23
Figures by quarter
Quarter Turnover, € State taxes, € Labour taxes, € Employees
Q3 2023 — 1 691 1 833 —
Q2 2023 — 930 1 011 1

Financials by year

2022 – 2023
Revenue, € 2023: 5 818 € · +1 354.5% vs 2022 · industry median 76 € · above 64% of the industry
02 0004 0006 0002022 Company: 400 € Industry median: 103 €20222023 Company: 5 818 € Industry median: 76 €202302 0004 0006 0002022 Company: 400 € Industry median: 103 €2023 Company: 5 818 € Industry median: 76 €2023
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit, € 2023: 662 € · +74.2% vs 2022 · industry median 0 € · above 60% of the industry
02004006008002022 Company: 380 € Industry median: 0 €20222023 Company: 662 € Industry median: 0 €202302004006008002022 Company: 380 € Industry median: 0 €2023 Company: 662 € Industry median: 0 €2023
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit margin, % 2023: 11.4 % · industry median 16.8 % · above 45% of the industry
051015202022 Company: — Industry median: 17.7 %20222023 Company: 11.4 % Industry median: 16.8 %2023051015202022 Company: — Industry median: 17.7 %2023 Company: 11.4 % Industry median: 16.8 %2023
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Assets, € 2023: 23 914 € · +33.3% vs 2022
05 00010 00015 00020 00025 0002022 Company: 17 946 €20222023 Company: 23 914 €202305 00010 00015 00020 00025 0002022 Company: 17 946 €2023 Company: 23 914 €2023
Equity, € 2023: 1 548 € · +307.4% vs 2022
05001 0001 5002 0002022 Company: 380 €20222023 Company: 1 548 €202305001 0001 5002 0002022 Company: 380 €2023 Company: 1 548 €2023
Employees 2023: 1 · industry median 1 · above 5% of the industry
0.00.51.01.52.02022 Company: 0 Industry median: 220222023 Company: 1 Industry median: 120230.00.51.01.52.02022 Company: 0 Industry median: 22023 Company: 1 Industry median: 12023
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Financials by year
Year Revenue, € Net profit, € Labour costs, € Assets, € Equity, € Employees
2023 5 818 662 6 764 23 914 1 548 1
2022 400 380 0 17 946 380 0

Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.

Financial ratios for 2023

Net profit margin
11.4 %
Net profit / revenue
Return on equity (ROE)
42.8 %
Net profit / equity
Return on assets (ROA)
2.8 %
Net profit / assets
Equity ratio
6.5 %
Equity / assets
Debt ratio
93.5 %
Liabilities / assets
Revenue per employee
5 818 €
Revenue / average full-time employees
Labour cost per employee per month
564 €
Labour costs / employees / 12 months (incl. employer taxes)

Annual reports

PDFs from e-Äriregister
Annual reports
Year Period Filed Report Documents
2023 1 Jan 2023 – 31 Dec 2023 5 Aug 2024 Company’s own e-Äriregister
2022 14 Jan 2022 – 31 Dec 2022 21 Jul 2023 Company’s own e-Äriregister

Board

Right of representation

Any member of the management board may represent the private limited company in all transactions.

Owners

Owner in

Beneficial owners

Founders and other persons

Activities (EMTAK)

  • 7211Research and experimental development on biotechnology Main

Rulings 3

All rulings (PDF)
Rulings
Number, date Title Deadline State Document
Ä 50194433 / M1
19 Jul 2024
 Warning of a fine: annual report not filed 18 Aug 2024 Deficiencies eliminated
6 Aug 2024
 PDF
Ä 50194433 / 2
1 Sep 2023
 Amendment entry In force
1 Sep 2023
 PDF
Ä 50194433
14 Jan 2022
 First entry In force
14 Jan 2022
 PDF

Sources: e-Äriregister and EMTA. Data updated 31 Oct 2026. Open at the source ↗ · Report an error in the data